Fully operational, revenue-generating German cannabis group with integrated operations across medical cannabis/CBD and industrial hemp verticals. Structured as a publicly listed European holding company, it provides broad exposure across the cannabis and hemp value chain in Germany and wider Europe. Founder-led team with 100+ years of cumulative industry experience, proprietary technology, and strategic partnerships support diversified revenue streams and a scalable platform.
Business Highlights
Scale and Growth Trajectory
- €16M revenue in 2024 (stated)
- On track for €26M revenue in 2025, with projected €47M by 2027 (stated)
- Clear path to positive EBITDA targeted Q1 to Q2 2026 (stated)
- Projected gross margins around 32% for 2025 to 2029 (stated)
Integrated, Multi-Vertical Platform
- Pharmaceutical distribution and EU-compliant supply chain positioning
- Cannabinoid manufacturing with GMP and GDP-aligned operations
- Product innovation plus proprietary technology including patented purification methods
Industrial Hemp Expansion Engine
- High-growth hemp applications spanning cultivation, extraction, and ingredient development
- Pathways referenced for food/feed ingredients and Novel Food registration
Digital Health Enablement
- Online ecosystem connecting patients, pharmacies, and healthcare professionals
- Foundation for telehealth and digital prescription enablement
European Market Access
- Turnkey route into Germany with broader EU operations and import/export capabilities
- Positioned to benefit from European medical cannabis market expansion dynamics
Investment Opportunity
Seeking €3.9 to €4.2 million investment to support strategic entry, expansion, or synergy. Strong fit for investment firms, consolidators, healthcare and pharma groups, cannabis operators, and food and wellness brands targeting Germany and Europe.
